{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T13:21:16Z","timestamp":1774444876406,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ahj.2018.09.008","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T02:48:52Z","timestamp":1539053332000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects"],"prefix":"10.1016","volume":"207","author":[{"given":"Blandine","family":"Mond\u00e9sert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Philippon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Dubuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Amit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Exner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Joza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernice","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Korley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danna","family":"Spears","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angie","family":"Djuric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Hruczkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidal","family":"Essebag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff S.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2018.09.008_bb0005","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.09.008_bb0010","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.09.008_bb0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.09.008_bb0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter\u2013defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.09.008_bb0025","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near- fatal ventricular arrhythmias","volume":"337","author":"Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.09.008_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000198","article-title":"A systematic review of ICD complications in randomised controlled trials versus registries: is our \u2018real-world\u2019 data an under- estimation?","volume":"2","author":"Ezzat","year":"2015","journal-title":"Open Heart"},{"issue":"9970","key":"10.1016\/j.ahj.2018.09.008_bb0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(14)61903-6","article-title":"Shockless IMPLant Evaluation [SIMPLE] investigators. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomized controlled trial (SIMPLE)","volume":"385","author":"Healey","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ahj.2018.09.008_bb0040","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jacc.2009.11.029","article-title":"For Investigators of the Ontario ICD Database. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database","volume":"55","author":"Lee","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ahj.2018.09.008_bb0045","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.hrthm.2013.06.021","article-title":"Transvenous extraction of implantable cardioverter-defibrillator leads under advisory - a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads","volume":"10","author":"Brunner","year":"2013","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.ahj.2018.09.008_bb0050","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.hrthm.2012.04.003","article-title":"Class I recall of defibrillator leads: a comparison of the Sprint Fidelis and Riata families","volume":"9","author":"Liu","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2018.09.008_bb0055","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.hrthm.2013.08.030","article-title":"Prevalence of externalized conductors in Riata and Riata ST silicone leads: Results from the prospective, multicenter Riata Lead Evaluation Study","volume":"10","author":"Hayes","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2018.09.008_bb0060","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.hrthm.2013.01.018","article-title":"Failure rate of the Riata lead under advisory: a report from the CHRS Device Committee","volume":"10","author":"Parkash","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2018.09.008_bb0065","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/CIRCULATIONAHA.111.053744","article-title":"Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee","volume":"125","author":"Birnie","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.09.008_bb0070","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.hrthm.2013.09.067","article-title":"A cost-effectiveness analysis of a proactive management strategy for the Sprint Fidelis recall: a probabilistic decision analysis model","volume":"10","author":"Bashir","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2018.09.008_bb0075","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.hrthm.2008.01.029","article-title":"Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee","volume":"5","author":"Krahn","year":"2008","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ahj.2018.09.008_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hrthm.2015.09.010","article-title":"Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications","volume":"13","author":"Olde Nordkamp","year":"2016","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.ahj.2018.09.008_bb0085","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/europace\/euq075","article-title":"Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study","volume":"12","author":"Korkeila","year":"2010","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.ahj.2018.09.008_bb0090","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1055\/s-0035-1553351","article-title":"Venous Obstruction in Asymptomatic Patients Undergoing First Implantation or Revision of a Cardiac Pacemaker or Implantable Cardioverter-Defibrillator: A Retrospective Single Center Analysis","volume":"187","author":"Pieper","year":"2015","journal-title":"Rofo"},{"key":"10.1016\/j.ahj.2018.09.008_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1874192401408010113","article-title":"Tricuspid valve regurgitation following temporary or permanent endocardial lead insertion, and the impact of cardiac resynchronization therapy","volume":"8","author":"Sadreddini","year":"2014","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.ahj.2018.09.008_bb0100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/pace.12530","article-title":"Tricuspid regurgitation and implantable devices","volume":"38","author":"Al-Bawardy","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"issue":"6","key":"10.1016\/j.ahj.2018.09.008_bb0105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.5603\/CJ.a2015.0060","article-title":"Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions","volume":"22","author":"Arabi","year":"2015","journal-title":"Cardiol J"},{"issue":"10","key":"10.1016\/j.ahj.2018.09.008_bb0110","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jacc.2005.02.037","article-title":"Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads","volume":"45","author":"Lin","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ahj.2018.09.008_bb0115","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/heartjnl-2013-304673","article-title":"Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up","volume":"100","author":"H\u00f6ke","year":"2014","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ahj.2018.09.008_bb0120","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.amjcard.2015.12.038","article-title":"Tricuspid Regurgitation and Mortality in Patients With Transvenous PermanentPacemaker Leads","volume":"117","author":"Delling","year":"2016","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.09.008_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5339\/gcsp.2015.41","article-title":"Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and design","volume":"2015","author":"Dokainish","year":"2015","journal-title":"Glob Cardiol Sci Pract"},{"issue":"7","key":"10.1016\/j.ahj.2018.09.008_bb0130","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.hrthm.2018.02.026","article-title":"Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial","volume":"15","author":"Schleifer","year":"2018","journal-title":"Heart Rhythm"},{"issue":"40","key":"10.1016\/j.ahj.2018.09.008_bb0135","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/eurheartj\/ehx080","article-title":"The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes","volume":"38","author":"Bongiorni","year":"2017","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ahj.2018.09.008_bb0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jacc.2009.08.070","article-title":"Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions","volume":"55","author":"Wazni","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2018.09.008_bb0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/sdi.12249","article-title":"Cardiovascular implantable electronic devices in hemodialysis patients: prevalence and implications for arteriovenous hemodialysis access interventions","volume":"28","author":"Saad","year":"2015","journal-title":"Semin Dial"},{"issue":"3","key":"10.1016\/j.ahj.2018.09.008_bb0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.ajkd.2011.03.026","article-title":"Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States","volume":"58","author":"Charytan","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.ahj.2018.09.008_bb0155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000366453","article-title":"Outcomes of infected cardiovascular implantable devices in dialysis patients","volume":"40","author":"Opelami","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ahj.2018.09.008_bb0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter\u2013 defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.09.008_bb0165","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCEP.111.964676","article-title":"Subcutaneous implantable cardioverter defibrillator","volume":"5","author":"Rowley","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"19","key":"10.1016\/j.ahj.2018.09.008_bb0170","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2016.08.044","article-title":"Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy","volume":"68","author":"Brouwer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2018.09.008_bb0175","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.09.008_bb0180","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.ahj.2018.09.008_bb0185","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE Study and EFFORTLESS Registry","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2018.09.008_bb0190","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: The EFFORTLESS Study","volume":"70","author":"Boersma","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2018.09.008_bb0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.hrthm.2015.08.039","article-title":"Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction","volume":"13","author":"Boersma","year":"2016","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.ahj.2018.09.008_bb0200","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/europace\/euv299","article-title":"The learning curve associated with the introduction of the subcutaneous implantable defibrillator","volume":"18","author":"Knops","year":"2016","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.ahj.2018.09.008_bb0205","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.hrthm.2017.05.016","article-title":"Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results","volume":"14","author":"Gold","year":"2017","journal-title":"Heart Rhythm"},{"issue":"17","key":"10.1016\/j.ahj.2018.09.008_bb0210","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/heartjnl-2016-310852","article-title":"Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review","volume":"103","author":"Chue","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2018.09.008_bb0215","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijcard.2016.11.017","article-title":"A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs transvenous implantable cardioverter defibrillator","volume":"228","author":"Honarbakhsh","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2018.09.008_bb0220","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euy083","article-title":"Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies","author":"Brouwer","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2018.09.008_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/jce.13498","article-title":"Six-year follow-up of the initial dutch subcutaneous implantable cardioverter-defibrillator cohort: Long term complications, replacements and battery longevity","author":"Quast","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2018.09.008_bb0230","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1540-8167.2011.02199.x","article-title":"Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study","volume":"23","author":"Gold","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.09.008_bb0235","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jce.12612","article-title":"A new algorithm to reduce inappropriate therapy in the S-ICD system","volume":"26","author":"Brisben","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"10.1016\/j.ahj.2018.09.008_bb0240","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.hrthm.2018.05.011","article-title":"Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator","volume":"15","author":"Theuns","year":"2018","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ahj.2018.09.008_bb0245","first-page":"174","article-title":"Canadian Cardiovascular Society\/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines","volume":"33","author":"Bennett","year":"2017","journal-title":"Can J Cardiol"},{"issue":"41","key":"10.1016\/j.ahj.2018.09.008_bb0250","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ahj.2018.09.008_bb0255","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004338","article-title":"Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease","volume":"9","author":"Moore","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"10.1016\/j.ahj.2018.09.008_bb0260","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4330\/wjc.v9.i6.547","article-title":"Entirely subcutaneous defibrillator and complex congenital heart disease: Data on long-term clinical follow-up","volume":"9","author":"Ferrero","year":"2017","journal-title":"World J Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2018.09.008_bb0265","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ahj.2012.02.012","article-title":"Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2018.09.008_bb0270","series-title":"The Need for Pacing in patients who qualify for an ICD: Clinical Implications. ESC Abstract","author":"Kutyifa","year":"2014"},{"issue":"1","key":"10.1016\/j.ahj.2018.09.008_bb0275","doi-asserted-by":"crossref","first-page":"e004663","DOI":"10.1161\/CIRCEP.116.004663","article-title":"Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator: An Evaluation of 4 Implantation Techniques","volume":"10","author":"Brouwer","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"10.1016\/j.ahj.2018.09.008_rf0280","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.hrthm.2013.05.016","article-title":"Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator","volume":"10","author":"Knops","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2018.09.008_rf0285","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","article-title":"Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years","volume":"115","author":"Kleemann","year":"2007","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ahj.2018.09.008_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002418","article-title":"Transvenous implantable cardioverter-defibrillator (ICD) lead performance: a meta-analysis of observational studies","volume":"4","author":"Provid\u00eancia","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2018.09.008_bb0295","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2010.06.059","article-title":"Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality","volume":"57","author":"van Rees","year":"2011","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:01:23Z","timestamp":1757570483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318302771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":59,"alternative-id":["S0002870318302771"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.09.008","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}